Chief Strategy Officer. Mr. Zheng is primarily responsible for the overall resource allocation and commercialization program and supports the research and development team. Mr. Zheng graduated from Yonsei University in Korea with a master's degree in business administration. He has held senior management positions with several Chinese and Korean biotechnology companies and has extensive experience in the development and commercialization of cell therapy products.
Mr. Zheng Xuanzhe